PORTOLA PHARMACEUTICALS INC. overview

Portola Pharmaceuticals Announces Virtual 2020 Annual Stockholder Meeting PR Newswire SOUTH SAN FRANCISCO, Calif., May 18, 2020 SOUTH SAN FRANCISCO, Calif. , May 18, 2020 /PRNewswire/ -- Portola Pharmaceuticals, Inc. ® (NASDAQ: PTLA) today announced that, due to the public health impact of the coronavirus (COVID-19) pandemic and to prioritize the health and well-being of stockholders, employees and other meeting participants, the location and format of its 2020 Annual Stockholder Meeting (the...

U.S. Centers for Medicare & Medicaid Services (CMS) Proposes Extending New Technology Add-on Payment (NTAP) Reimbursement for Portola Pharmaceuticals' Andexxa® for Third Year - Reinforcing Breakthrough Innovation and Clinical Value of Andexxa, Proposed Extension Will Support Patient Access by Continuing to Provide Medicare Reimbursement in the Hospital Setting - PR Newswire SOUTH SAN FRANCISCO, Calif., May 14, 2020 SOUTH SAN FRANCISCO, Calif. , May 14, 2020 /PRNewswire/ -- Portola...

Portola Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Corporate Update - Reached Agreement to be Acquired by Alexion; Transaction Expected to Close in Third Quarter - - Andexxa®/Ondexxya® Global Net Product Revenues of $25.6 Million - PR Newswire SOUTH SAN FRANCISCO, Calif., May 11, 2020 SOUTH SAN FRANCISCO, Calif. , May 11, 2020 /PRNewswire/ -- Portola Pharmaceuticals, Inc. ® (Nasdaq: PTLA) today reported financial results for the three months ended March 31,...

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Portola Pharmaceuticals, Inc. - PTLA PR Newswire NEW YORK, May 6, 2020 NEW YORK , May 6, 2020 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City , is investigating Portola Pharmaceuticals, Inc. ("Portola" or the "Company") (NasdaqGS: PTLA) relating to the sale of the Company to Alexion...

SHAREHOLDER ALERT: WeissLaw LLP Investigates Portola Pharmaceuticals, Inc. PR Newswire NEW YORK, May 5, 2020 NEW YORK , May 5, 2020 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Portola Pharmaceuticals, Inc. ("PTLA" or the "Company") (NASDAQ: PTLA) in connection with the proposed acquisition of the Company by Alexion Pharmaceuticals, Inc. ("ALXN") (NASDAQ: ALXN). Under the terms of the acquisition...

Portola Pharmaceuticals Cancels First Quarter 2020 Financial Results Webcast and Conference Call Following Agreement to be Acquired by Alexion PR Newswire SOUTH SAN FRANCISCO, Calif., May 5, 2020 SOUTH SAN FRANCISCO, Calif. , May 5, 2020 /PRNewswire/ -- Portola Pharmaceuticals, Inc. ® (NASDAQ: PTLA) (the "Company" or " Portola ") today announced that it is cancelling its webcast and conference call to discuss the Company's financial results for the first quarter ended March 31, 2020 that was...

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Portola Pharmaceuticals, Inc. PR Newswire NEW YORK, May 5, 2020 NEW YORK , May 5, 2020 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) and its board of directors concerning the proposed acquisition of the company by Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN). Stockholders will receive $18.00 for each share of Portola Pharmaceuticals stock that...

Thinking about buying stock in Portola Pharmaceuticals, Norwegian Cruise Line, Tetra Technologies, Wayfair, or Chegg? PR Newswire NEW YORK, May 5, 2020 NEW YORK , May 5, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PTLA, NCLH, TTI, W, and CHGG. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. PTLA:...